PagerDuty Inc (PD) Stock News

The State Street SPDR S&P Homebuilders ETF (XHB) is not recommended as a suitable option for investors seeking to outperform in the Industrials ETFs segment. The fund has declined 12.9% over the past year with high volatility (beta of 1.25, standard deviation of 26.77%), concentrated exposure with only 35 holdings, and a dividend yield of just 0.69%. Investors are advised to consider alternative options like market cap weighted ETFs or other homebuilder-focused funds.

The State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) is highlighted as a strong option for investors seeking large-cap value exposure. With $45.92 billion in assets, a low 0.16% expense ratio, and a Zacks ETF Rank of 1 (Strong Buy), DIA has gained 12.02% year-to-date and 18.46% over the past year. The ETF holds 31 blue-chip stocks with heavy exposure to Financials (27.5%), led by holdings in Goldman Sachs, Caterpillar, and Microsoft.

The author recommends SPDR Gold Shares (GLD) as the best gold ETF for most investors, citing its size ($146B AUM), global accessibility across multiple exchanges, and transparent holdings verification. While its 0.4% expense ratio is higher than competitors, it remains a practical inflation hedge, especially during periods of elevated inflation. The author maintains a ~4% portfolio allocation to GLD.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and ensure fair value for shareholders. The investigations involve Personalis (acquired by Tempus AI for $16.25/share), Werewolf Therapeutics (acquired by Ambros Therapeutics), Beazer Homes (acquired by Dream Finders Homes for $33.50/share), and MarketAxess Holdings (acquired by Intercontinental Exchange for $167/share).

PODCAST: UPDATE: Gloria Steinem, Iran's economy and the Pentagon's testosterone pullback  Reuters

The State Street SPDR S&P Software & Services ETF (XSW) is a smart beta ETF launched in 2011 that tracks the S&P Software & Services Select Industry Index. With $491.1 million in assets and a low expense ratio of 0.35%, it offers broad exposure to the software sector with 133 holdings. The fund has gained 7.91% year-to-date and 7% over the past year, but carries higher risk with a beta of 1.17 and standard deviation of 26.90%. Investors seeking lower-risk alternatives may consider traditional market cap-weighted ETFs.

XLU, a passively managed utilities sector ETF launched in 1998, offers low-cost exposure to the utilities sector with a 0.08% expense ratio and $21.9 billion in assets. The fund has delivered 1.09% year-to-date returns and 3.78% over the past year, with a medium-risk profile (beta of 0.57). It holds a Zacks ETF Rank of 2 (Buy) and is recommended as an outstanding option for utilities sector exposure, though investors should consider alternatives like FUTY and VPU.

The State Street SPDR NYSE Technology ETF (XNTK) is a passively managed fund tracking 35 U.S. technology companies with a low 0.35% expense ratio and $1.85 billion in assets. The ETF has gained 26.7% year-to-date and 45.7% over the past year, earning a Zacks ETF Rank of 1 (Strong Buy). However, it carries higher volatility with a beta of 1.45 and concentrated exposure with only 37 holdings.

The State Street SPDR S&P Homebuilders ETF (XHB) is a passively managed fund offering exposure to homebuilders and construction companies. Despite low expense ratios of 0.35%, the ETF has underperformed with a 9.19% decline over the past year and carries high risk with a beta of 1.25. Zacks assigned it a Rank 4 (Sell) rating, recommending investors consider alternatives like the Invesco Building & Construction ETF (PKB) instead.

The article reviews MDY, a mid-cap blend ETF with $26.42 billion in assets and a 0.23% expense ratio. The fund has returned approximately 15% year-to-date and 16.64% over the past year, with a beta of 1.01 indicating medium risk. MDY receives a Zacks ETF Rank of 3 (Hold) and is compared to lower-cost alternatives like Vanguard's VO (0.03% expense ratio) and iShares' IJH (0.05% expense ratio).

The State Street SPDR S&P Oil & Gas Equipment & Services ETF (XES) offers low-cost exposure to the energy equipment and services sector with a 0.35% expense ratio and strong year-to-date performance of 71.69%. However, it carries high risk with a standard deviation of 32.93% and concentrated holdings. The ETF received a Zacks ETF Rank of 2 (Buy) and is recommended for investors seeking sector exposure, with alternatives like IEZ and OIH also available.

SPSM, a passively managed small-cap blend ETF with $17.09 billion in assets, offers broad exposure to the US small-cap market with an extremely low expense ratio of 0.03%. The fund has gained 22.55% year-to-date and 25.02% over the past year, earning a Zacks ETF Rank of 1 (Strong Buy). With 610 holdings and a beta of 1.02, it provides effective diversification for long-term investors seeking small-cap exposure.

PagerDuty reported Q3 2026 earnings of $0.32 per share, beating consensus estimates of $0.30, with revenues of $124.44 million slightly exceeding expectations. However, the stock has declined 7% year-to-date compared to the S&P 500's 12.1% gain. The company received a Zacks Rank #3 (Hold) rating, suggesting near-term performance in line with the market.

Xanadu Quantum Technologies and Mitsubishi Chemical have announced the second phase of their collaboration to advance quantum computing applications in semiconductor fabrication, specifically for extreme ultraviolet (EUV) lithography. The partnership, supported by Canada's National Research Council Industrial Research Assistance Program (NRC IRAP) and Japan's Strategic Innovation Promotion Program (SIP), aims to develop a fault-tolerant quantum computing-ready software pipeline to identify materials that prevent radiation-induced blurring in chip manufacturing.

PayPoint plc announced the monthly acquisition of Partnership Shares and corresponding Matching Shares awards under its Share Incentive Plan on 24 August 2026. Multiple PDMRs and Executive Directors, including Chief Financial Officer David Robert Harding and Chief Executive Officer Nicholas Wiles, participated in the scheme at a price of £6.202182 per share.

Schwab International Equity ETF (SCHF) and State Street SPDR Portfolio Developed World ex-US ETF (SPDW) both offer low-cost international exposure with identical 0.03% expense ratios. While Schwab delivered slightly higher returns and lower volatility over five years, State Street provides broader diversification with nearly 1,000 additional holdings including small-cap stocks, which the author favors for long-term growth potential.

The article compares two healthcare-focused ETFs: iShares Global Healthcare ETF (IXJ) and State Street SPDR S&P Biotech ETF (XBI). XBI delivered superior 1-year returns of 80.2% with small-cap biotech focus but carries higher volatility (54% max drawdown). IXJ offers more stability with lower volatility, higher dividend yield (1.4%), and international diversification across large-cap pharmaceutical and healthcare companies. The analysis recommends XBI for long-term investors prioritizing performance despite greater risk.

PayPoint Plc announced that deferred bonus plan awards granted to PDMRs on 31 July 2023 vested on 5 August 2026 after meeting continuous employment conditions. A total of 28,402 net vested shares were distributed across nine executives, with some shares sold on the London Stock Exchange. Additionally, PDMRs reinvested interim cash dividends to purchase ordinary shares under the Share Incentive Plan.

Shell plc's Chief Financial Officer Sinead Gorman sold 30,000 ordinary shares on July 31, 2026, at £33.69 per share for a total of £1,010,596.95 on the London Stock Exchange. The transaction was disclosed in accordance with EU and UK market abuse regulations.

Law firm Brodsky & Smith announced investigations into four major merger transactions, examining whether the boards of MarketAxess Holdings, CBIZ, Sanara MedTech, and TriCo Bancshares breached fiduciary duties by failing to conduct fair processes and potentially underpaying shareholders. The firm is seeking shareholders to discuss potential class action lawsuits.

SPGM and SPDW are two State Street ETFs offering different approaches to global investing. SPGM provides broad global exposure with 61% U.S. holdings and lower volatility, while SPDW focuses on developed international markets with a lower expense ratio (0.03% vs 0.09%) and higher dividend yield (3.10% vs 1.80%). SPGM has outperformed over the past decade with a 12.3% CAGR versus SPDW's 9.9%, but both can serve useful roles depending on investor goals.

Peter Kendall has completed his mandate as Interim Chief Executive Officer of ARCpoint Inc. after 45 days, delivering his assessment and recommendations to the Board. His RSU grant has been pro-rated from 4 million to 2 million shares. The Board is now considering his recommendations and will seek to appoint a new CEO. Kendall will continue as an advisory consultant.

A comprehensive analysis reveals over 180 companies developing 200+ PD-1 and PD-L1 inhibitor drugs across various clinical stages. The report highlights major pharmaceutical players advancing pipeline therapies for multiple cancer indications, with approximately 15+ drugs in late-stage development and 30+ in mid and early stages. Recent developments include FDA breakthrough designations and positive clinical trial results for combination therapies.

Glucotrack, Inc. (NASDAQ: GCTK) completed a strategic business combination with Lōkahi Therapeutics, creating a publicly listed platform for identifying and advancing healthcare assets. Lōkahi Therapeutics securityholders will hold approximately 90% of the combined company on a fully diluted basis. Erik Emerson was appointed CEO, while Glucotrack's continuous blood glucose monitoring (CBGM) technology will operate as a separate subsidiary under Paul Goode's leadership. The transaction is supported by a planned private placement financing.

PDF Solutions, Inc. (Nasdaq: PDFS) announced it will release its Second quarter fiscal 2026 financial results on August 6, 2026, followed by a live teleconference with CEO John Kibarian and CFO Adnan Raza at 2:00 p.m. Pacific Time to discuss the results. The call will be webcast on the company's investor relations website.

Predictive Discovery Limited (PDI) announced a USD 10 million strategic investment in Awalé Resources Limited, acquiring approximately 12.3% stake. The investment will fund exploration activities in Awalé's Odienné gold and copper project in Côte d'Ivoire, which includes a joint venture with Newmont Corporation reporting 1.71 million ounces of gold equivalent in measured resources.

Predictive Discovery Limited (PDI) announced a $10 million strategic investment in South African exploration company Awalé Resources Limited, acquiring a 12.3% stake. The investment will fund exploration activities on Awalé's Odienné gold project in Côte d'Ivoire, which includes a joint venture with Newmont Corporation containing estimated mineral resources of 1.71 million ounces of gold equivalent.

Shell plc has notified that following the June 29, 2026 interim dividend payment for Q1 2026, multiple Persons Discharging Managerial Responsibilities (PDMRs) including CEO Wael Sawan and CFO Sinead Gorman acquired dividend shares through employee share plans. The transactions occurred on July 2, 2026, across multiple currencies and exchanges, with share prices ranging from EUR 33.9265 to GBP 28.87677 per ordinary share.

UMH Properties reported strong second quarter 2026 performance with 10.3% increase in total rental income, record home sales of $11.4 million, and net occupancy gains of 139 units. The company strengthened its balance sheet through preferred share issuance and successfully amended its revolving credit line to $260 million with improved terms, positioning itself for continued growth through its substantial inventory of vacant sites and land.

Law firm Levi & Korsinsky has filed a class action lawsuit against ZoomInfo Technologies Inc. on behalf of investors who purchased securities between November 3, 2025 and May 11, 2026. The lawsuit alleges the company made materially false and misleading statements about its growth, customer retention, and market trends while concealing adverse facts. ZoomInfo's stock price fell approximately 33% (from $6.04 to $4.06 per share) following the announcement of disappointing Q1 2026 results and reduced 2026 guidance. The lead plaintiff deadline is August 24, 2026.